Tafamidis meglumine
Product Specifications
CAS Number
951395-08-7
Synonyms
Vyndaqel, Fx-1006A
SKU
C03406-5mg
Target
Others
Applications
Others
Additionnal Information
Tafamidis meglumine (Vyndaqel, Fx-1006A) stabilizes the tetrameric structure of transthyretin (TTR) by binding to thyroxine-binding sites. Tafamidis meglumine treats transthyretin familial amyloid polyneuropathies (TTR-FAP), a condition characterized by neurological damage from TTR amyloidosis, by preventing the misfolding and aggregation of transthyretin (TTR) into amyloid fibrils.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6320865-01 0.2 mL
MINPP1, CT (MINPP1, MIPP, Multiple inositol polyphosphate phosphatase 1, 2,3-bisphosphoglycerate 3-phosphatase, Inositol (1,3,4,5) -tetrakisphosphate 3-phosphatase) (PE)
Ask
View Details